Orchard Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug '25 Aug 12, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	3	34	-	-	-	-
Enterprise Value	-40	-1	-	-	-	-
Last Close Price	0.11	1.53	-	-	-	-
PE Ratio	0.65	16.13	-	-	-	-
PS Ratio	0.09	2.24	-	-	-	-
PB Ratio	0.03	0.48	-	-	-	-
P/TBV Ratio	0.03	0.48	-	-	-	-
P/FCF Ratio	0.80	11.31	-	-	-	-
P/OCF Ratio	0.74	10.41	-	-	-	-
Debt / Equity Ratio	0.00	0.00	0.05	0.05	0.06	0.07
Debt / EBITDA Ratio	0.06	0.06	0.23	0.21	0.27	0.34
Debt / FCF Ratio	0.07	0.07	0.27	0.20	4.72	0.78
Asset Turnover	0.22	0.22	0.39	0.46	0.51	-
Inventory Turnover	5.71	5.71	5.72	5.77	5.51	-
Quick Ratio	23.79	23.79	8.41	7.84	5.20	3.09
Current Ratio	24.81	24.81	8.86	8.42	5.92	3.69
Return on Equity (ROE)	3.14%	3.14%	19.88%	24.17%	23.38%	-
Return on Assets (ROA)	1.86%	1.86%	11.50%	14.21%	13.54%	-
Return on Capital (ROIC)	1.91%	1.91%	11.75%	14.37%	13.87%	-
Return on Capital Employed (ROCE)	3.00%	3.00%	18.00%	22.50%	20.80%	18.80%
Earnings Yield	87.34%	6.20%	-	-	-	-
FCF Yield	124.57%	8.84%	-	-	-	-
Buyback Yield / Dilution	-3.42%	-3.42%	-	-	-	-

Updated Dec 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q